$120.0 Million
Arvinas
Initial Public Offering
Active Bookrunner
$117.3 Million
Crinetics Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$138.0 Million
OptiNose AS
Initial Public Offering
Active Bookrunner
$136.9 Million
Menlo Therapeutics Inc.
Initial Public Offering
Active Bookrunner
$107.5 Million
Neuronetics, Inc.
Initial Public Offering
Active Bookrunner
$46.0 Million
Arsanis Inc.
Initial Public Offering
Passive Bookrunner
$138.8 Million
Deciphera Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$42.2 Million
ASLAN Pharmaceuticals Pte. Ltd.
Initial Public Offering
Active Bookrunner
$172.5 Million
Day One Biopharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$76.3 Million
Ra Medical Systems Inc.
Initial Public Offering
Left Bookrunner
Subscribe to Equity Capital Markets

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.